These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11188908)

  • 21. TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.
    Babiuk S; Mookherjee N; Pontarollo R; Griebel P; van Drunen Littel-van den Hurk S; Hecker R; Babiuk L
    Immunology; 2004 Sep; 113(1):114-20. PubMed ID: 15312142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined DNA vaccination against three animal viruses elicits decreased immunogenicity of a single plasmid in mice.
    Wang KY; Guo YJ; Zhang YL; Lv K; Sun SH
    Vaccine; 2007 May; 25(22):4429-36. PubMed ID: 17420075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The processing of antigens delivered as DNA vaccines.
    Howarth M; Elliott T
    Immunol Rev; 2004 Jun; 199():27-39. PubMed ID: 15233724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens.
    Pavlenko M; Leder C; Pisa P
    Expert Rev Vaccines; 2005 Jun; 4(3):315-27. PubMed ID: 16026247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immune responses in rainbow trout after DNA immunization against the viral hemorrhagic septicemia virus.
    Utke K; Kock H; Schuetze H; Bergmann SM; Lorenzen N; Einer-Jensen K; Köllner B; Dalmo RA; Vesely T; Ototake M; Fischer U
    Dev Comp Immunol; 2008; 32(3):239-52. PubMed ID: 17629943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modifying professional antigen-presenting cells to enhance DNA vaccine potency.
    Hung CF; Yang M; Wu TC
    Methods Mol Med; 2006; 127():199-220. PubMed ID: 16988456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
    Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
    Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of immunity using oral DNA vaccines expressing the measles virus nucleocapsid protein.
    Fooks AR; Sharpe SA; Shallcross JA; Clegg JC; Cranage MP
    Dev Biol (Basel); 2000; 104():65-71. PubMed ID: 11713826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virosomes for antigen and DNA delivery.
    Daemen T; de Mare A; Bungener L; de Jonge J; Huckriede A; Wilschut J
    Adv Drug Deliv Rev; 2005 Jan; 57(3):451-63. PubMed ID: 15560951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells.
    Ma K; Xu W; Shao X; Yanyue ; Hu L; Xu H; Yuan Z; Zheng X; Xiong S
    Antiviral Res; 2007 Nov; 76(2):140-9. PubMed ID: 17655942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depletion of CD25+ cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein.
    Mincheff M; Zoubak S; Altankova I; Tchakarov S; Pogribnyy P; Makogonenko Y; Botev C; Meryman HT
    Cancer Gene Ther; 2005 Feb; 12(2):185-97. PubMed ID: 15375382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL; Doolan DL
    Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The protective mechanisms induced by a fish rhabdovirus DNA vaccine depend on temperature.
    Lorenzen E; Einer-Jensen K; Rasmussen JS; Kjaer TE; Collet B; Secombes CJ; Lorenzen N
    Vaccine; 2009 Jun; 27(29):3870-80. PubMed ID: 19427083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Entrapment of plasmid DNA vaccines into liposomes by dehydration/rehydration.
    Gregoriadis G; McCormack B; Obrenovich M; Perrie Y
    Methods Mol Med; 2000; 29():305-11. PubMed ID: 21374330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Naked DNA for inoculation and therapy].
    Mölling K
    Dtsch Med Wochenschr; 1997 Jun; 122(23):757-60. PubMed ID: 9229554
    [No Abstract]   [Full Text] [Related]  

  • 38. Report of the Meeting on Genetic Vaccines (Naked DNA/RNA) WHO Geneva, May 17-18, 1994.
    Ramírez JL
    Mem Inst Oswaldo Cruz; 1994; 89(2):297-8. PubMed ID: 7533886
    [No Abstract]   [Full Text] [Related]  

  • 39. The mechanism of naked DNA uptake and expression.
    Wolff JA; Budker V
    Adv Genet; 2005; 54():3-20. PubMed ID: 16096005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Naked DNA vaccines].
    Spitz M
    Medicina (B Aires); 2000; 60(5 Pt 1):639-44. PubMed ID: 11188908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.